In a recent study published in The Lancet Digital Health, researchers discuss the development and validation of a combined model comprising imaging, clinical, and cell-free deoxyribonucleic acid (DNA) ...

For predicting relapse in 1,387 patients with early-stage (I-II) NSCLC from the Spanish Lung Cancer Group data (average age 65.7 years, female 24.8%, male 75.2%), we train tabular and graph machine ...

Lung cancer remains the single most common etiology of cancer-related mortality globally, with most patients diagnosed at advanced stages when treatment efficacy is limited. Detecting lung cancer ...

A new study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...

Radiation fractionation effect on IDO1 through NF-kB/COX2 axis in non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a ...

BioMark Diagnostics ( ($TSE:BUX) ) has provided an announcement. BioMark Diagnostics Inc. and its research partners have been honored with the ...

Sectional view of the exhaled breath sampling equipment (left); the equipment connected with an air bag (right). (CC BY/JAMA Network Open 10.1001/jamanetworkopen.2021.3486) Breathe in, breathe out.

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.